Enhanced Digital Features To view enhanced digital features for this article go to Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
The case series in Medicine specifically highlighted this mechanism, noting that the body water loss associated with GLP-1 agonists may be more significant than commonly appreciated
Foundayo (Orforglipron) Foundayo, approved in 2026, represents a daily pill with no dosing restrictions, offering simplicity and flexibility for users
Eating a substantial meal before and while consuming alcohol significantly reduces peak blood alcohol levels and gastric distress